Keywords , weight loss , liver fibrosis , phase 3 clinical trial , metabolic syndrome , non-invasive tests 0 1 INTRODUCTION Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a leading cause of chronic liver disease worldwide, tightly linked to obesity, type 2 diabetes mellitus (T2DM), and other components of the metabolic syndrome [1]
Mood and cognitive effects GIP and GLP-1 receptors exist in the brain
While some people may start to see weight loss and other benefits early on, others may need a bit more time
Otherwise, you might accidentally hit a muscle or blood vessel, which can be painful and cause bruising
If you become pregnant whilst taking any weight loss medication, stop the medicine and seek medical advice promptly
If time zones interfere with your schedule, discuss how to adjust your next dose with your doctor